Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
Frontiers in Reproductive Health|February 6, 2023
Semen parameters and male reproductive potential are not adversely affected after three or more months of recovery from COVID-19 diseaseSara Stigliani, Claudia Massarotti, Francesca Bovis, et al.
Rheumatology International|April 12, 2018
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Neil Martin, Joyce Davidson, Catriona Anderson, et al.
Rheumatology International|April 12, 2018
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Jose Antonio Melo-Gomes, Filipa Oliveira-Ramos, Alessandro Consolaro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2017
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMSFrancesca Bovis, Nicola De Stefano, Joshua R Steinerman, et al.
Annals of Neurology|October 9, 2024
Relapse-Associated and Relapse-Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different ErasNoemi Montobbio, Cinzia Cordioli, Alessio Signori, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Therapeutic lag: Is treatment effect delayed in progressive MS?Noemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysisIrene Schiavetti, Marta Ponzano, Alessio Signori, et al.
Rheumatology International|April 12, 2018
The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Sulaiman M Al-Mayouf, Ashwaq AlE'ed, Mohammed Muzaffer, et al.
Rheumatology International|April 12, 2018
The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Maya-Feriel Aiche, Hachemi Djoudi, Sulaiman Al-Mayouf, et al.
Reproduction & Fertility|February 8, 2024
Algorithm vs. clinical experience: controlled ovarian stimulations with follitropin-delta and individualised doses of follitropin-alpha/betaIrene Gazzo, Francesca Bovis, Denise Colia, et al.
Pageof 19